Clinical Trial Update: Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation [Phase 3]

View source ↗

Summary

Phase 3 trial comparing oral ondansetron to transdermal granisetron for cervical, endometrial, or vaginal cancer patients undergoing pelvic chemoradiation; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer
• Vaginal Cancer

Drugs mentioned

• Granisetron transdermal (Sancuso) (granisetron)
• Ondansetron (oral) (ondansetron)
• SANCUSO (GRANISETRON)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Cancer of the Cervix | Phase 3 | Status: COMPLETED | Results posted: 2021-05-17